Topokine Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $346M

Topokine General Information

Description

Developer of therapies for dermatology and medical aesthetics. The company develops topical medications for non-invasive contouring of the face and body. It develops non-invasive therapies for subcutaneous fat disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 60 South Street
  • Suite 1120
  • Boston, MA 02111
  • United States
Primary Industry
Drug Discovery
Acquirer
Corporate Office
  • 60 South Street
  • Suite 1120
  • Boston, MA 02111
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Topokine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 21-Apr-2016 $346M Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 02-Apr-2014 Completed Clinical Trials - Phase 2
1. Early Stage VC 22-Jan-2013 Completed Clinical Trials - Phase 1
To view Topokine’s complete valuation and funding history, request access »

Topokine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Topokine’s complete cap table history, request access »

Topokine Patents

Topokine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10188661-B2 Topical dosage regimen Active 27-Jun-2014
US-20170202852-A1 Topical dosage regimen Active 27-Jun-2014
US-10869874-B2 Methods and compositions for topical delivery of prostaglandins to subcutaneous fat Active 15-May-2013
US-20160067263-A1 Methods and compositions for topical delivery of prostaglandins to subcutaneous fat Active 15-May-2013
US-20180169111-A1 Methods and compositions for topical delivery of prostaglandins to subcutaneous fat Active 15-May-2013 A61K31/5575
To view Topokine’s complete patent history, request access »

Topokine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Topokine Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Schooner Capital Growth/Expansion Minority
To view Topokine’s complete investors history, request access »

Topokine FAQs

  • When was Topokine founded?

    Topokine was founded in 2010.

  • Where is Topokine headquartered?

    Topokine is headquartered in Boston, MA.

  • What is the size of Topokine?

    Topokine has 2 total employees.

  • What industry is Topokine in?

    Topokine’s primary industry is Drug Discovery.

  • Is Topokine a private or public company?

    Topokine is a Private company.

  • What is the current valuation of Topokine?

    The current valuation of Topokine is .

  • What is Topokine’s current revenue?

    The current revenue for Topokine is .

  • How much funding has Topokine raised over time?

    Topokine has raised $3.98M.

  • Who are Topokine’s investors?

    Schooner Capital has invested in Topokine.

  • When was Topokine acquired?

    Topokine was acquired on 21-Apr-2016.

  • Who acquired Topokine?

    Topokine was acquired by Allergan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »